n-(3-oxo-octanoyl)-l-homoserine lactone has been researched along with (S)-4,5-dihydroxypentane-2,3-dione in 1 studies
Studies (n-(3-oxo-octanoyl)-l-homoserine lactone) | Trials (n-(3-oxo-octanoyl)-l-homoserine lactone) | Recent Studies (post-2010) (n-(3-oxo-octanoyl)-l-homoserine lactone) | Studies ((S)-4,5-dihydroxypentane-2,3-dione) | Trials ((S)-4,5-dihydroxypentane-2,3-dione) | Recent Studies (post-2010) ((S)-4,5-dihydroxypentane-2,3-dione) |
---|---|---|---|---|---|
33 | 0 | 10 | 7 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Janda, KD; Kaufmann, GF; Lowery, CA; Salzameda, NT; Sawada, D | 1 |
1 other study(ies) available for n-(3-oxo-octanoyl)-l-homoserine lactone and (S)-4,5-dihydroxypentane-2,3-dione
Article | Year |
---|---|
Medicinal chemistry as a conduit for the modulation of quorum sensing.
Topics: Acyl-Butyrolactones; Animals; Anti-Bacterial Agents; Drug Discovery; Gram-Negative Bacteria; Gram-Positive Bacteria; Homoserine; Humans; Lactones; Molecular Structure; Pentanes; Peptides, Cyclic; Quorum Sensing; Structure-Activity Relationship | 2010 |